To Investigate the Clinical Efficacy of an Experimental Toothpaste

NCT ID: NCT01079910

Last Updated: 2018-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE1

Study Classification

INTERVENTIONAL

Study Start Date

2009-12-09

Study Completion Date

2009-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the effect of an experimental toothpaste on maintaining gingival health over a 24 week period measured through modified gingival index, bleeding, plaque, and plaque bacteria. Prior to commencing study treatment, subjects will undergo a dental prophylaxis followed by a 2 week period of oral hygiene instruction and weekly professional tooth cleaning to bring the subjects to their optimum gingival health prior to commencing study treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental toothpaste

0.1% isopropylmethylphenol and 1150ppm fluoride

Group Type EXPERIMENTAL

isopropylmethylphenol and Fluoride

Intervention Type DRUG

0.1% isopropylmethylphenol and 1150ppm fluoride

Marketed toothpaste

NaF/Silica toothpaste containing 1150ppm fluoride

Group Type OTHER

Fluoride and Silica

Intervention Type DRUG

NaF/Silica toothpaste containing 1150ppm fluoride

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

isopropylmethylphenol and Fluoride

0.1% isopropylmethylphenol and 1150ppm fluoride

Intervention Type DRUG

Fluoride and Silica

NaF/Silica toothpaste containing 1150ppm fluoride

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subjects aged 18 years and older
* A minimum of 20 permanent gradable teeth
* For baseline eligibility, subjects must have a minimum Modified Gingival Index score of 1.5-2.3.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

T3450803

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Study to Evaluate Dental Plaque
NCT00758290 COMPLETED PHASE3